New Treatments in Progress

Summary provided by Teepa Snow, Dementia Care Specialist

Clinical Phases

• Pre-clinical—drugs are studied in test tube situations or on animal models
• Phase I—tested on a small number of healthy humans to see what a safe dose would be
• Phase II—testing safety and effectiveness in a small number of patients; not enough people to justify it being used by everyone with the condition
• Phase III—large scale trial designed to test safety and effectiveness that would be adequate for FDA approval
• Submit testing results for FDA approval
• Phase IV—post-approval studies done to make sure the treatment is safe and to promote further investigations
Drugs must go through clinical trials in phases before being approved for usage in the U.S.

Read more: New Treatments in Progress

University Research

Duke University

Joseph and Kathleen Bryan Alzheimer's Disease Research Center

University of North Carolina-Chapel Hill

Memory Disorders Division, Department of Neurology

University of North Carolina-Wilmington

Department of Psychology

Memory Assessment and Research Services